The dual delivery of IL-2 and GM-CSF to EpCAM-expressing colon carcinoma in vivo resulted in less lung metastases at low doses, but the effect of the dual immunocytokine was not greater than the single cytokine-carrying molecules [111]. The gene discussed is CSF2; the disease is colon carcinoma.